JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (1): 5-10.doi: 10.6040/j.issn.1671-7554.0.2016.1331
Previous Articles Next Articles
DENG Xiaohui, XU Yaxuan
CLC Number:
| [1] American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589[J]. Fertil Steril, 2014, 101(3): 633-663. [2] 王若琳, 钱卫平, 周亮, 等. 高龄对卵母细胞质量的影响[J]. 生殖与避孕, 2016, 36(9): 752-757. [3] Demko ZP, Simon AL, McCoy RC, et al. Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening[J]. Fertil Steril, 2016, 105(5): 1307-1313. [4] Roberts SA, Hiest WM, Brison DR, et al. Embryo and uterine influences on IVF outcomes: an analysis of a UK multi-centre cohort[J]. Hum Reprod, 2010, 25(11): 2792-2802. [5] Seckin B, Turkcapar F, Ozaksit G. Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women[J]. J Assist Reprod Genet, 2012, 29(3): 231-236. [6] Cui L, Qin Y, Gao X, et al. Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause[J]. Fertil Steril, 2016, 105(2): 481-485. [7] Barbakadze L, Kristesashvili J, Khonelidze N, et al. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women[J]. Int J Fertil Steril, 2015, 8(4): 393-398. [8] Gohari MR, Ramezani Tehrani F, Chenouri S, et al. Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone[J]. Menopause, 2016, 23(8): 839-845. [9] Tehrani FR, Solaymani-Dodaran M, Tohidi M, et al. Modeling age at menopause using serum concentration of anti-mullerian hormone[J]. J Clin Endocrinol Metab, 2013, 98(2): 729-735. [10] Sahmay S, Oncul M, Tuten A, et al. Anti-müllerian hormone levels as a predictor of the pregnancy rate in women of advanced reproductive age[J]. J Assist Reprod Genet, 2014, 31(11):1469-1474. [11] Lukaszuk K, Liss J, Kunicki M, et al. Anti-Müllerian hormone(AMH)is a strong predictor of live birth in women undergoing assisted reproductive technology[J]. Reprod Biol, 2014, 14(3): 176-181. [12] Tal R, Tal O, Seifer BJ, et al. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: asystematic review and meta-analysis[J]. Fertil Steril, 2015, 103(1): 119-130. [13] Li Y, Nie M, Liu Y, et al. The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome[J]. Gynecol Endocrinol, 2015, 31(6): 450-453. [14] Tsakos E, Tolikas A, Daniilidis A, et al. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET[J]. Archives of Gynecology and Obstetrics, 2014, 290(6): 1249-1253. [15] Vladimirov IK, Tacheva DM, Kalinov KB. Mean ovarian diameter(MOD)as a predictor of poor ovarian response[J]. J Assist Reprod Genet, 2004, 21(3): 73-77. [16] Gingold JA, Lee JA, Rodriguez-Purata J, et al. Endometrial pattern, but not endometrial thickness, affects implantation rates in euploid embryo transfers[J]. Fertil Steril, 2015, 104(3): 620-628. [17] Yuan X, Saravelos SH, Wang Q, et al. Endometrial thickness as a predictor of pregnancy outcomes in 10787 fresh IVF-ICSI cycles[J]. Reprod Biomed Online, 2016, 33(2): 197-205. [18] Joo JK, Jeong JE, Kim CW, et al. Quantitative Assessment of Endometrial Volume and Uterine Vascularity and Pregnancy Outcome in Frozen-Thawed Embryo Transfer Cycles[J]. J Reprod Med,2016, 61(3-4): 133-138. [19] 何玉洁, 王瑛, 土增荣, 等. 体外受精-胚胎移植过程中子宫收缩与妊娠结局相关性分析[J]. 中国药物与临床, 2015, 15(9): 1249-1252. HE Yujie, WANG Ying, TU Zengrong, et al. Collection between uterine contraction and pregnancy outcome in IVF/ICSI cycle[J]. Chinese Remedies & Clinics, 2015, 15(9): 1249-1252. [20] Rabotti C, Sammali F, Kuijsters N, et al. Analysis of uterine activity in nonpregnant women by electrohysterography: a feasibility study[J]. Conf Proc IEEE Eng Med Biol Soc, 2015, 2015: 5916-5919. doi: 10.1109/EMBC.2015.7319738. [21] Trolice MP. Live birth from a 46-year-old using fresh autologous oocytes through in vitro fertilization[J]. Fertil Steril, 2014, 102(1): 96-98. [22] Yan G, Xie X, Wang Y, et al. Twin pregnancy after intracytoplasmic sperm injection in woman aged 49 using autologous oocytes by mild ovarian stimulation: a case report[J]. Int J Clin Exp Med, 2015, 8(11): 21707-21709. [23] Demko ZP, Simon AL, McCoy RC, et al. Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening[J]. Fertil Steril, 2016, 105(5): 1307-1313. [24] Gomes LM, Canha Ados S, Dzik A, et al. The age as a predictive factor in in vitro fertilization cycles[J]. Rev Bras Ginecol Obstet, 2009, 31(5): 230-234. [25] Gleicher N, Kushnir VA, Albertini DF, et al. Improvements in IVF in women of advanced age[J]. J Endocrinol, 2016, 230(1): 1-6. [26] Wennberg AL, Opdahl S, Bergh C, et al. Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology[J]. Fertil Steril, 2016, 106(5): 1142-1149. [27] Davies MJ, Rumbold AR, Marino JL, et al. Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study[J]. BJOG, 2016, doi: 10.1111/1471-0528.14365. [Epub ahead of print]. [28] Lee RK, Wu FS, Lin MH, et al. The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age[J]. Reprod Biol Endocrinol, 2011, 9: 115. doi: 10.1186/1477-7827-9-115. [29] Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial(FORT-T)[J]. Fertil Steril, 2014, 101(6): 1574-1581. [30] Li Y, Yang W, Chen X, et al. Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response[J]. Gynecol Endocrinol, 2016, 32(1): 74-77. [31] Bassiouny YA, Dakhly DM, Bayoumi YA, et al. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial[J]. Fertil Steril, 2016, 105(3): 697-702. [32] 鹿群, 沈浣, 王丛, 等. 脱氢表雄酮对卵巢反应不良患者体外受精-胚胎移植的影响[J]. 山东大学学报(医学版), 2013, 5(12): 84-92. LU Qun, SHEN Huan, WANG Cong, et al. Dehydroepiandrosterone supplementation improve in vitro fertilization outcome among women with poor response[J]. Journal of Shandong University(Health Sciences), 2013, 5(12): 84-92. [33] Gat I, Blanco Mejia S, Balakier H, et al. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve[J]. Gynecol Endocrinol, 2016, 32(7): 534-537. [34] Fernando S, Rombauts L. Melatonin: shedding light on infertility? ——A review of the recent literature[J]. J Ovarian Res, 2014, 7: 98. Published online 2014 Oct 21. doi: 10.1186/s13048-014-0098-y. [35] Zhou L, Xia Y, Ma X, et al. Effects of “enstrual cycle-based acupuncture therapy” on IVF-ET in patients with decline in ovarian reserve[J]. Zhong Guo Zhen Jiu, 2016, 36(1): 25-28. [36] Younis JS, Izhaki I, Ben-Ami M, et al. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study[J]. Clin Endocrinol(Oxf), 2016, 84(1): 99-106. [37] Schwarze JE, Crosby JA, Zegers-Hochschild F. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis[J]. Fertil Steril, 2016, 106(7):1714-1717.e1. [38] Bastu E, Buyru F, Ozsurmeli M, et al. A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 203: 30-34. doi: 10.1016/j.ejogrb.2016.05.027. [39] Yasa C, Bastu E, Dural O, et al. Evaluation of low-dose letrozole addition to ovulation induction in IVF.Evaluation of low-dose letrozole addition to ovulation induction in IVF[J]. Clin Exp Obstet Gynecol, 2013, 40(1): 98-100. [40] Suzuki N, Yoshioka N, Takae S. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency[J]. Hum Reprod, 2015, 30(3): 608-615. [41] Paulson RJ, Fauser BC, Vuong LT, et al. Can we modify assisted reproductive technology practice to broaden reproductive care access?[J]. Fertil Steril, 2016, 105(5): 1138-1143. [42] Fang C, Tang J, Huang R, et al. Comparison of IVF outcomes using conventional insemination and ICSI in ovarian cycles in which only one or two oocytes are obtained[J]. J Gynecol Obstet Biol Reprod(Paris), 2012, 41(7): 650-656. [43] Tannus S, Son WY, Gilman A, et al. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age[J]. Hum Reprod, 2016, doi:10.1093/humrep/dew298. [44] Lee HL, McCxulloh DH, Hodes-Wertz B, et al. In vitro fertilization with preimplantation genetic screening improves implantation and live birth in women age 40 through 43[J]. J Assist Reprod Genet, 2015, 32(3): 435-444. [45] Lathi RB, Kort JD. Caution: counseling patients with diminished ovarian reserve and recurrent pregnancy loss about in vitro fertilization with preimplantation genetic screening[J]. Fertil Steril, 2016, 106(5): 1041-1042. [46] 罗燕群, 刘风华, 易艳红, 等. 年龄、移植胚胎数量、质量与临床妊娠率的关系[J]. 生殖医学杂志, 2014, 23(5): 361-366. LUO Yanqun, LIU Fenghua, YI Yanhong, et al. Effect of number and quality of embryo transferred on clinical pregnancy rate in women of different age[J]. J Reprod Med, 2014, 23(5): 361-366. [47] Toner JP, Grainger DA, Frazier LM. Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996-1998[J]. Fertil Steril, 2002, 78(5): 1038-1045. [48] Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion[J]. Fertil Steril, 2016, 106(5): 3-7. |
| [1] | LI Mei. Quality of oocytes and embryos of elder women [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 16-21. |
| [2] | CHEN Zijiang. Clinical concern of the second pregnancy under the two-child policy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 1-4. |
| [3] | ZHU Yimin. Risk of birth defects and cognitive disorder of children conceived by assisted reproduction technology in couples with advanced parental age [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 11-15. |
| [4] | YANG Dongzi, MAI Zhuoyao. Features of ovarian reserve and outcomes of assisted reproductive technology in elder patients with PCOS [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 26-32. |
| [5] | SHI Yuhua, LI Jing. Strategies for infertility treatment in elderly women [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 22-25. |
| [6] | XI Xianghong, SU Rong, JIA Shaotong, TANG Xiuying, WANG Lixin. Correlation between human epididymis protein 4 in seminal plasma and male infertility [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 66-69. |
| [7] | WANG Likui, SANG Hongai, MA Yuyan, XU Yintao, WANG Linlin. Clinical characteristics and pregnancy outcomes of patients with systemic lupus erythematosus: a study of 66 cases with 67 pregnancies [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 69-72. |
| [8] | LI Qi, SUN Yixin, LI Yixue, ZHANG Cuiqin, WU Rongshan, XUE Fuzhong. Spacial distribution of fertility rate in Shandong Province and its influencing factors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 107-112. |
| [9] |
.
Effect of systematic prenatal health education and appropriate prenatal diagnosis on pregnancy outcome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(9): 134-136. |
| [10] |
CHANG Fuli，LI Shuling ， LI Yuzhu . Kidneybenefiting and conceptionaiding granules in treating infertility due to ovulatory dysfunction [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(02): 82-84. |
|
||
